obinutuzumab
ItalyDrugs containing this active substance
-
This medicinal product is used in adults for the treatment of Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), and Lupus Nephritis (LN).
Form: solution for infusion, concentrate
Active substance Dosage obinutuzumab - ATC: L01FA03
Manufacturer: ROCHE REGISTRATION GMBH